Welcome to
Endpoints News’
manufacturing briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
Telix Pharmaceuticals is
acquiring
Texas-based radiopharma
and bioconjugate company IsoTherapeutics in a deal that includes $8 million up front. This will bring manufacturing in-house for Australian biotech Telix, according to a Tuesday release.
Dynavax Technologies touted its decreasing manufacturing
costs per unit for its hepatitis B vaccineHEPLISAV-B, attributing this to “a number of investments in manufacturing,” said CFO Kelly MacDonald during an investor call on Feb. 22. The company made investments at its antigen manufacturing facility in Düsseldorf, Germany, which has helped the company to improve its yield of HEPLISAV-B.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.